CAS 11056-06-7: Bleomicina

Descrizione: Bleomicina è un antibiotico glicopeptidico che viene utilizzato principalmente nella chemioterapia per il cancro. È derivato dal batterio Streptomyces verticillus ed è noto per la sua capacità di indurre rotture nei filamenti di DNA, il che porta all'inibizione della crescita delle cellule tumorali. Il composto presenta un meccanismo d'azione unico legandosi al DNA e generando radicali liberi in presenza di ossigeno, causando danni ossidativi. Bleomicina è particolarmente efficace contro alcuni tipi di tumori, tra cui il cancro testicolare e il linfoma di Hodgkin. Viene somministrato per iniezione e può causare effetti collaterali come tossicità polmonare, reazioni cutanee e febbre. La sostanza è caratterizzata dal suo peso molecolare relativamente basso e da una struttura complessa che include un sito di legame per metalli, cruciale per la sua attività. A causa della sua azione specifica sulle cellule in rapida divisione, Bleomicina è spesso utilizzato in combinazione con altri agenti chemioterapici per migliorare l'efficacia del trattamento riducendo al minimo la resistenza. Il suo utilizzo richiede un attento monitoraggio a causa dei potenziali effetti avversi, in particolare sulla funzione polmonare.

Formula: Unspecified

InChI: InChI=1/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29?,30?,34-,35-,36-,37?,38?,39?,40?,41-,42?,43?,53?,54?/m0/s1

Sinonimi:

• Blenamax
• Bleo
• Bleo-Kyowa
• Bleocin
• Bleomycins
• Nsc 125066
• [2-[2-[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxo-propyl)amino]-3-oxo-propyl]-5-methyl-pyrimidine-4-carbonyl]amino]-3-[[4-[[1-[2-[4-[4-(4-guanidinobutylcarbamoyl)thiazol-2-yl]thiazol-2-yl]ethylcarbamoyl]-2-hydroxy-propyl]amino]-2-hydroxy-1,3-dimethyl-4-oxo-butyl]amino]-1-(3H-imidazol-4-yl)-3-oxo-propoxy]-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-4-yl] carbamate
• (3-{[(2'-{(5S,8S,9S,10R,13S)-15-{6-amino-2-[(1S)-3-amino-1-{[(2S)-2,3-diamino-3-oxopropyl]amino}-3-oxopropyl]-5-methylpyrimidin-4-yl}-13-[(R)-{[3-{[4-(carbamoyloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}(1H-imidazol-5-yl)methyl]-9-hydroxy-5-[(1R)-1-hydroxyethyl]-8,10-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazapentadec-1-yl}-2,4'-bi-1,3-thiazol-4-yl)carbonyl]amino}propyl)(dimethyl)sulfonium (non-preferred name)
• N1-(3-(dimethylsulfonio)propyl)bleomycinamide) (Bleomycin A2)
• BLM
• Blenoxane
• (2R,3S,4S,5R,6R)-2-({(3S,4S,5S,6S)-2-[2-{[(6-amino-2-{3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl}-5-methylpyrimidin-4-yl)carbonyl]amino}-3-[(4-{[1-({2-[4-({4-[(diaminomethylidene)amino]butyl}carbamoyl)-2,4'-bi-1,3-thiazol-2'-yl]ethyl}carbamoyl)-2-hydroxypropyl]amino}-2-hydroxy-1,3-dimethyl-4-oxobutyl)amino]-1-(1H-imidazol-5-yl)-3-oxopropoxy]-6-ethyl-4,5-dimethyltetrahydro-2H-pyran-3-yl}oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl carbamate
• 3-[[2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxo-propyl)amino]-3-oxo-propyl]-5-methyl-pyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-3-(3H-imidazol-4-yl)propanoyl]amino]-3-hydroxy-2-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]ethyl]thiazol-4-yl]thiazole-4-carbonyl]amino]propyl-dimethyl-sulfonium
• Bleomycin
• (3-{[(2'-{(5S,8S,9S,10R,13S)-15-{6-amino-2-[(1S)-3-amino-1-{[(2S)-2,3-diamino-3-oxopropyl]amino}-3-oxopropyl]-5-methylpyrimidin-4-yl}-13-[{[(2R,3S,4S,5S,6S)-3-{[(2R,3S,4S,5R,6R)-4-(carbamoyloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}(1H-imidazol-5-yl)methyl]-9-hydroxy-5-[(1R)-1-hydroxyethyl]-8,10-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazapentadec-1-yl}-2,4'-bi-1,3-thiazol-4-yl)carbonyl]amino}propyl)(dimethyl)sulfonium (non-preferred name)

Bleomycin Sulfate (mixture)

CAS: 11056-06-79041-93-4

• Purezza: >85.0%(HPLC)
• Colore e forma: White to Light yellow powder to crystal

Bleomycin

CAS: 11056-06-7

Please enquire for more information about Bleomycin including the price, delivery time and more detailed …

• Formula: C₅₅H₈₄N₁₇O₂₁S₃
• Purezza: Min. 95%
• Peso molecolare: 1,415.56 g/mol

Bleomycin Free Base

CAS: 11056-06-7

Bleomycin Free Base, a glycopeptide antibiotic, halts DNA function and treats solid tumors.

• Formula: C₅₅H₈₄N₁₇O₂₁S₃
• Colore e forma: Liquid
• Peso molecolare: 1415.55